All In MedTech

PMA device

Kamra Inlay

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

4

PMA pathway

Device trials

6

Naming "Kamra Inlay"

MAUDE reports

9

Brand "Kamra Inlay", since 2015

PubMed studies

29

Mentioning "Kamra Inlay"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Kamra Inlay

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 4 of 4 decisions filed under this name.

1 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Kamra Inlay", any status and sponsor, newest update first.

Open in Trial Radar

3 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Kamra Inlay", and for the whole product code for context.

This brand

9 reports: 0 malfunction, 9 injury, 0 death

Whole product code LQE

297 reports: 34 malfunction, 263 injury, 0 death

Newest reports for this brand

  • CORNEAGEN

    3005357288-2019-00005 · Received May 31, 2019 · Event dated Apr 26, 2019

    Device type: Implant, Corneal, Refractive (LQE)

    Device problem as coded: Adverse Event Without Identified Device or Use Problem

    Patient problem as coded: Abdominal Pain; Corneal Clouding/Hazing

  • CORNEAGEN

    3005357288-2019-00002 · Received Apr 5, 2019 · Event dated Mar 8, 2019

    Device type: Implant, Corneal, Refractive (LQE)

    Device problem as coded: Patient Device Interaction Problem

    Patient problem as coded: Foreign Body Sensation in Eye; Patient Problem/Medical Problem

  • CORNEAGEN

    3005357288-2019-00003 · Received Apr 5, 2019 · Event dated Mar 14, 2019

    Device type: Implant, Corneal, Refractive (LQE)

    Device problem as coded: Adverse Event Without Identified Device or Use Problem

    Patient problem as coded: Visual Impairment

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Kamra Inlay"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code LQE.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.